Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing ATRIPLA listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

ATRIPLA
Tenofovir Disoproxil Fumarate
Emtricitabine
Canada

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

ATRIPLA

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 28 USDMF, 12 EU WC, 2 KDMF, 22 NDC API, 19 Listed Suppliers, $ API Reference Price

40 API Suppliers
28 USDMF
12 EU WC
2 KDMF
22 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

196 FDF Dossiers, 59 FDA Orange Book, 40 Europe, 11 Canada, 67 South Africa, 19 Listed Dossiers

196 FDF Dossiers
59 FDA Orange Book
40 Europe
11 Canada
67 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG;300MG;300MG, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, TABLET;ORAL - 600MG;200MG;300MG

TABLET;ORAL - 400MG;300MG;300MG
CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG
TABLET;ORAL - 600MG;200MG;300MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 8 DKSH, 1 Jai Radhe Sales, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 29 Controlled & Modified Release, 25 Disintegrants & Superdisintegrants, 22 Direct Compression, 21 Thickeners and Stabilizers, 17 Lubricants & Glidants, 17 Granulation, 11 Co-Processed Excipients, 10 Topical, 9 Empty Capsules, 8 Film Formers & Plasticizers, 6 Taste Masking, 5 Parenteral, 5 API Stability Enhancers, 5 Coloring Agents, 5 Solubilizers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 1 Surfactant & Foaming Agents

52 Coating Systems & Additives
49 Fillers, Diluents & Binders
29 Controlled & Modified Release
25 Disintegrants & Superdisintegrants
22 Direct Compression
21 Thickeners and Stabilizers
17 Lubricants & Glidants
17 Granulation
11 Co-Processed Excipients
10 Topical
9 Empty Capsules
8 Film Formers & Plasticizers
6 Taste Masking
5 Parenteral
5 API Stability Enhancers
5 Coloring Agents
5 Solubilizers
4 Emulsifying Agents
4 Vegetarian Capsules
3 Rheology Modifiers
3 Chewable & Orodispersible Aids
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 55 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
55 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 24 Finished Drug Prices, 15 Annual Reports

3 US Medicaid Prescriptions
24 Finished Drug Prices
15 Annual Reports

MARKET PLACE

8 APIs, 5 FDF Dossiers

8 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 10 Health Canada Patents

10 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 USP, 5 Others

5 USP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 95 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

11 All

01 1APOTEX INC

02 2AURO PHARMA INC

03 2JAMP PHARMA CORPORATION

04 1LABORATOIRE RIVA INC.

05 2MYLAN PHARMACEUTICALS ULC

06 1PHARMASCIENCE INC

07 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

11 All

01 11EFAVIRENZ

filter Dosage Form Reset all filters

11 All

01 11TABLET

filter Brand Name Reset all filters

11 All

01 1APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

02 1AURO-EFAVIRENZ

03 1AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

04 1JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

05 1JAMP-EFAVIRENZ

06 1MYLAN-EFAVIRENZ

07 1MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

08 1PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

09 1RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR

10 1TEVA-EFAVIRENZ

11 1TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR

FDF Dossiers
FDA Orange Book
Europe
Canada
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

APOTEX INC

AAPS 2024

Not Confirmed

APOTEX INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30/90

Approval Date :

Application Number : 2468247

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AURO PHARMA INC

AAPS 2024

Not Confirmed

AURO PHARMA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30

Approval Date :

Application Number : 2478404

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AURO PHARMA INC

AAPS 2024

Not Confirmed

AURO PHARMA INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : AURO-EFAVIRENZ

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 10/30/90/500

Approval Date :

Application Number : 2418428

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

JAMP PHARMA CORPORATION

AAPS 2024

Not Confirmed

JAMP PHARMA CORPORATION

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : JAMP-EFAVIRENZ

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30

Approval Date :

Application Number : 2458233

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

PHARMASCIENCE INC

AAPS 2024

Not Confirmed

PHARMASCIENCE INC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number : 2487284

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

06

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30

Approval Date :

Application Number : 2393549

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-EFAVIRENZ

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30

Approval Date :

Application Number : 2389762

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MYLAN PHARMACEUTICALS ULC

AAPS 2024

Not Confirmed

MYLAN PHARMACEUTICALS ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30

Approval Date :

Application Number : 2461412

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MYLAN PHARMACEUTICALS ULC

AAPS 2024

Not Confirmed

MYLAN PHARMACEUTICALS ULC

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : MYLAN-EFAVIRENZ

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging : 30/100

Approval Date :

Application Number : 2381524

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

LABORATOIRE RIVA INC.

Country

AAPS 2024

Not Confirmed

LABORATOIRE RIVA INC.

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number : 2518716

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?